Tracking Diabetes: New York City's A1C Registry
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Context:In December 2005, in characterizing diabetes as an epidemic, the New York City Board of Health mandated the laboratory reporting of hemoglobin A1C laboratory test results. This mandate established the United States’ first population‐based registry to track the level of blood sugar control in people with diabetes. But mandatory A1C reporting has provoked debate regarding the role of public health agencies in the control of noncommunicable diseases and, more specifically, both privacy and the doctor‐patient relationship. Methods:This article reviews the rationale for adopting the rule requiring the reporting of A1C test results, experience with its implementation, and criticisms raised in the context of the history of public health practice. Findings:For many decades, public health agencies have used identifiable information collected through mandatory laboratory reporting to monitor the population's health and develop programs for the control of communicable and noncommunicable diseases. The registry program sends quarterly patient rosters stratified by A1C level to more than one thousand medical providers, and it also sends letters, on the provider's letterhead whenever possible, to patients at risk of diabetes complications (A1C level >9 percent), advising medical follow‐up. The activities of the registry program are similar to those of programs for other reportable conditions and constitute a joint effort between a governmental public health agency and medical providers to improve patients’ health outcomes. Conclusions:Mandatory reporting has proven successful in helping combat other major epidemics. New York City's A1C Registry activities combine both traditional and novel public health approaches to reduce the burden of an epidemic chronic disease, diabetes. Despite criticism that mandatory reporting compromises individuals’ right to privacy without clear benefit, the early feedback has been positive and suggests that the benefits will outweigh the potential harms. Further evaluation will provide additional information that other local health jurisdictions may use in designing their strategies to address chronic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Improving Primary Care for Patients With Chronic Illness
Bodenheimer, T. (2002) · JAMA · doi:10.1001/jama.288.14.1775 · Cited by 2,961
Improving Primary Care for Patients With Chronic Illness: The Chronic Care Model, Part 2
Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002) · JAMA · doi:10.1001/jama.288.15.1909 · Cited by 2,413
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Physical Activity and Food Environments: Solutions to the Obesity Epidemic
SALLIS, J. F., & GLANZ, K. (2009) · The Milbank Quarterly · doi:10.1111/j.1468-0009.2009.00550.x · Cited by 722
Auchincloss, A. H., Diez Roux, A. V., Brown, D. G., Erdmann, C. A., & Bertoni, A. G. (2008) · Epidemiology · doi:10.1097/ede.0b013e31815c480 · Cited by 167
Cited by
Golden, S. H., Brown, A., Cauley, J. A., Chin, M. H., Gary-Webb, T. L., Kim, C., Sosa, J. A., Sumner, A. E., & Anton, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2043 · Cited by 405
Applications of Electronic Health Information in Public Health: Uses, Opportunities and Barriers
Tomines, A., Readhead, H., Readhead, A., & Teutsch, S. (2013) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.13063/2327-9214.1019 · Cited by 40
“2005, the New York City Board of Health mandated the laboratory reporting of hemoglobin A1C test results to track blood glucose levels in diabetes patients; while preliminary feedback has been positive, it has not been without controversy, and may provide important lessons for other health agencies.(58)”
BackgroundDistress and Type 2 Diabetes Self-Care: Putting the Pieces Together
Hoogendoorn, C. J., Schechter, C. B., Llabre, M. M., Walker, E. A., & Gonzalez, J. S. (2021) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa070 · Cited by 28
Schechter, C. B., Walker, E. A., Ortega, F. M., Chamany, S., & Silver, L. D. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.11.017 · Cited by 26
Self-citation
Metadata
- Authors
- CHAMANY, S., SILVER, L. D., BASSETT, M. T., DRIVER, C. R., BERGER, D. K., NEUHAUS, C. E., KUMAR, N., & FRIEDEN, T. R.
- Venue
- The Milbank Quarterly
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 87
- Issue
- 3
- Pages
- 547-570
- ISSN
- 0887-378X (ISSN-L)
- 1468-0009
- OpenAlex
- W2082068829
- Cited by
- 63
- References
- 7
- FWCI
- 7.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tracking Diabetes: New York City's A1C Registry. https://app.cochat.ai/papers/10.1111/j.1468-0009.2009.00568.x
- The paper
- CHAMANY, S., SILVER, L. D., BASSETT, M. T., DRIVER, C. R., BERGER, D. K., NEUHAUS, C. E., KUMAR, N., & FRIEDEN, T. R. (2009). Tracking Diabetes: New York City's A1C Registry. The Milbank Quarterly. https://doi.org/10.1111/j.1468-0009.2009.00568.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.